Biomarkers Could Point to Preclampsia Risk
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read MorePosted by Chris Wolski | Nov 11, 2022 | Prenatal Testing |
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Biochemicals & Chemical Reagents |
PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Gastrointestinal Infections |
ProciseDx Inc. announces it has received FDA clearance for its ProciseDx instrument and C reactive Protein (CRP) test.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Molecular Diagnostic Analyzers |
UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Diabetes & Metabolic Diseases |
Alimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read More